<DOC>
	<DOC>NCT00754507</DOC>
	<brief_summary>To determine the effects of WelChol tablets on serum lipids, lipoproteins, apolipoproteins, and lipoprotein particle size in patients who were stabilized on atorvastatin therapy for at least 4 weeks.</brief_summary>
	<brief_title>A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<criteria>Male or female &gt; or greater than 18 years of age On a stable dose of atorvastatin LDLC &gt; or = to 115 mg/dL and &lt; or = to 250 mg/dL TG &lt; or = to 300 mg/dL Women are not pregnant or breastfeeding or planning to become pregnant Women of childbearing potential had a hysterectomy or tuballigation, or women were post menopausal, or women practiced an acceptable method of contraception as specified in the protocol BMI &gt; 40 kg/m2 History of allergic or toxic reaction to colesevelam HCl History of swallowing disorders Any serious disorder that could impact the conduct of the study History of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>